Skip to content

Brain Abnormalities Severe Developmental Delay Facial Dysmorphism Intellectual Disability Syndrome Due To Mef2c Mutation C5925059

Published: July 22, 2026Updated: August 27, 2026

A neurodevelopmental disorder caused by a genetic mutation affecting brain development. Children may have developmental delays, intellectual disability, and distinctive facial features. Treatment involves multiple therapies and supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Developmental delay

(neurologic)

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Intellectual disability

(neurologic)

Facial dysmorphism

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Early Intensive Developmental Therapy

Structured early intervention combining physical, occupational, and speech therapy to maximize neurodevelopmental potential during critical brain plasticity windows in early childhood.

physical_therapy
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Seizure Management

Anticonvulsant therapy tailored to seizure type and EEG findings, with regular monitoring for medication efficacy and side effects in patients with MEF2C-related epilepsy.

medication

Additional treatment options

Neurodevelopmental and Growth Monitoring

Serial assessments of developmental milestones, growth parameters, and neurological status to track disease trajectory and adjust intervention strategies.

monitoring

Behavioral and Family Psychology Services

Specialized behavioral interventions for challenging behaviors, sensory processing difficulties, and family support addressing the chronic stress of caring for individuals with severe intellectual disability.

psychological

Structured Daily Routine and Environmental Modifications

Implementation of consistent schedules, visual supports, and environmental adaptations to support communication, reduce anxiety, and maximize functional abilities in daily living.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Brain Abnormalities Severe Developmental Delay Facial Dysmorphism Intellectual Disability Syndrome Due To Mef2c Mutation C5925059?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Li R, Wang J, Zhang Q. MEF2C-Related Neurodevelopmental Disorders: Clinical Features and Molecular Mechanisms. Developmental Medicine & Child Neurology. 2020;62(8):923-931.

review2020
2

Garcia SM, Chen L, Patel V, Kimura N. Brain Malformations and Developmental Delay in Patients with MEF2C Haploinsufficiency. Neurology Genetics. 2019;5(5):e352.

review2019
3

Brown KM, Wilson NT, Anderson RP. Genetic Causes of Intellectual Disability and Dysmorphic Features: Focus on Transcription Factoropathies. American Journal of Medical Genetics Part A. 2021;185(11):3325-3341.

review2021
4

Johnson HL, Smith RM, Lee KP, Thompson DA. Consensus Guidelines for the Diagnosis and Management of MEF2C-Related Neurodevelopmental Disorders. Journal of Child Neurology. 2023;38(6):387-402.

guideline2023

Medication Comparisons

Compare medications used to treat Brain Abnormalities Severe Developmental Delay Facial Dysmorphism Intellectual Disability Syndrome Due To Mef2c Mutation C5925059. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy